ISO 11737-3:2023 is the part of the ISO 11737 microbiological methods series that deals with bacterial endotoxin testing, and it applies to health care products, their components and raw materials. It sets the general criteria for determining bacterial endotoxins using amebocyte lysate reagents, so a supplier and a buyer can agree on what a result means. The most useful thing to hold on to is that an endotoxin test is not the same as a pyrogen test: a lysate-based method responds to endotoxin, and some pyrogens are not endotoxin at all.
What does ISO 11737-3:2023 cover?
The standard carries the title Sterilization of health care products, Microbiological methods, Part 3: Bacterial endotoxin testing. It covers the devices, components and raw materials a manufacturer puts through the test, and the pack examples in the text include pouches, reel goods, sterilization wrap and reusable containers.
It is a microbiological methods document. It tells you how to design and control the test, not what limit your own product has to meet. The standard supplies the method; the product specification supplies the limit.
How is endotoxin testing different from bioburden testing?
Bioburden testing counts the microorganisms present on or in a product before sterilization. Endotoxin testing measures a chemical residue, a lipopolysaccharide from the outer membrane of gram-negative bacteria, and it reports in endotoxin units rather than colony counts.
A product can carry a low bioburden and still carry endotoxin, and a product can be sterile and still be pyrogenic. The two tests answer different questions, which is why the ISO 11737 series devotes separate parts to each of them.
Which endotoxin method should a supplier use?
There is no single right answer; the method has to fit the product matrix and the purpose of the test. The four families below are the ones a buyer is most likely to see named in a report.
| Method | What it measures | Typical use | Limitation |
|---|---|---|---|
| Gel-clot LAL | Clot endpoint against a reference standard | Simple limit test | Semi-quantitative; operator-dependent read |
| Turbidimetric or chromogenic LAL | Optical change read kinetically or at endpoint | Quantitative release testing | Sensitive to inhibition or enhancement; needs controls |
| Recombinant Factor C (rFC) | Fluorescence from a recombinant enzyme cascade | Animal-free alternative | Method must be validated for the product matrix |
| Monocyte activation test (MAT) | Human cell response to pyrogens | Detects non-endotoxin pyrogens | Not a substitute for LAL in a release specification |
Two practical notes sit behind that table. Inhibition and enhancement controls are what make a quantitative result trustworthy, so a report without them is incomplete. A maximum valid dilution exists so that a sample can be diluted past interference without pushing the endotoxin below the detection limit.
Where do USP and Ph. Eur. chapters fit?
They operate at a different level. USP <85> and Ph. Eur. 2.6.14 are pharmacopoeial chapters that act as release requirements for pharmaceutical products, while ISO 11737-3 gives the general criteria for determining endotoxins on or in health care products, components and raw materials.
A supplier can be working to both, and should be able to say which one a given certificate is speaking to. That is the question to ask when a document says a lot simply passed.
What should a buyer see in an endotoxin test report?
At a minimum: the method, the reagent and its sensitivity, the endotoxin limit applied, the dilution used and the maximum valid dilution, the positive and negative controls, and the inhibition or enhancement result. The report should also name the lot.
If the text only says the lot passed with no method and no lot number, it is not evidence a quality system can use. A test report is only as useful as the chain that connects it to the goods on your shelf.
Which consumables matter for endotoxin testing in Canada?
In a laboratory the ordinary items carry the result: containers that do not shed endotoxin, sampling tools that are handled consistently, and a documented chain from sample to report. A sterile screw-cap specimen container and individually wrapped cotton swabs do not appear in the standard by name, but they appear in the procedure and in the lot records behind every result.
Related Reading
- Laboratory and clinical learning hub
- ISO 11737-1 and -2 bioburden and sterility testing
- Sterilization modalities: ISO 17665, 11135 and 11137
- autoclave log template
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.
wholesale account before you commit to a full case quantity.
Related Reading
- ISO 11737-1 and -2 bioburden and sterility testing
- Sterilization modalities: ISO 17665, 11135 and 11137
- Laboratory and clinical learning hub
- Wholesale and multi-site ordering
Frequently Asked Questions
Does ISO 11737-3 replace USP <85>?
No. They operate at different levels. ISO 11737-3 gives the general criteria for determining bacterial endotoxins on or in health care products, components and raw materials. The pharmacopoeial chapters such as USP <85> and Ph. Eur. 2.6.14 remain the release requirements for pharmaceutical products. A supplier can be testing against both.
What is a maximum valid dilution?
The highest dilution allowed by the endotoxin limit and the sensitivity of the reagent. It exists so a sample can be diluted past interference without diluting the endotoxin below the detection limit. The calculation and the inhibition or enhancement checks belong in the test report.
Can LAL testing detect every pyrogen?
No. Amebocyte lysate reagents respond to bacterial endotoxin. Non-endotoxin pyrogens, some of which come from gram-positive organisms, fungi or process residues, can be pyrogenic without triggering a lysate reaction. That is what the monocyte activation test is for.
Do sterile device packagers need endotoxin testing?
It depends on the route of contact. Devices that contact blood or cerebrospinal fluid often carry a pyrogen or endotoxin limit in their specification, which makes testing a release requirement. For most external devices the specification does not include one, and bioburden and sterility are the controlling measures.
CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire